BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2528737)

  • 1. 'Zoladex' versus 'Zoladex' plus flutamide in the treatment of advanced prostate cancer. First interim analysis of an international trial. International Prostate Cancer Study Group.
    Lunglmayr G
    Prog Clin Biol Res; 1989; 303():145-51. PubMed ID: 2528737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoladex and flutamide vs orchidectomy: a phase III EORTC 30853 trial. EORTC Urological Group.
    Carvalho AP; de Moura JL; Denis L; Newling D; Smith P; Bono A; Sylvester R; De Pauw M; Ongena P
    Prog Clin Biol Res; 1989; 303():129-43. PubMed ID: 2528736
    [No Abstract]   [Full Text] [Related]  

  • 3. [Randomized study comparing zoladex versus zoladex plus flutamide in treatment of advanced cancer of the prostate].
    Haefliger JM
    Helv Chir Acta; 1992 Oct; 59(3):477-83. PubMed ID: 1464545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total androgen ablation: European experience. The EORTC GU Group.
    Denis L; Smith P; Carneiro de Moura JL; Newling D; Bono A; Keuppens F; Mahler C; Robinson M; Sylvester R; De Pauw M
    Urol Clin North Am; 1991 Feb; 18(1):65-73. PubMed ID: 1825144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter trial comparing the luteinizing hormone releasing hormone analog Zoladex, with Zoladex plus flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group.
    Lunglmayr G
    Eur Urol; 1990; 18 Suppl 3():28-9. PubMed ID: 2151273
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined treatment (goserelin plus flutamide) versus monotherapy (goserelin alone) in advanced prostate cancer: a randomized study.
    Jurincic CD; Horlbeck R; Klippel KF
    Semin Oncol; 1991 Oct; 18(5 Suppl 6):21-5. PubMed ID: 1835139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lack of effect of therapy with LHRH analogs, alone or associated with flutamide, on prolactin levels in advanced prostatic carcinoma].
    Banchini A; Zavaroni D; Tarditi E; Cortellini P; Ziveri M; Polotti R; Stefani F; Valenti G
    Minerva Endocrinol; 1989; 14(3):165-8. PubMed ID: 2533662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between surgical orchidectomy and LH-RH analogue ('Zoladex', ICI 118,630) in the treatment of advanced prostatic carcinoma--a multi-centre clinical study.
    Kaisary AV; Ryan PG; Turkes A; Peeling WB; Griffiths K
    Prog Clin Biol Res; 1988; 260():89-100. PubMed ID: 2966408
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison between surgical orchidectomy and the LHRH agonist 'Zoladex' (ICI 188630) in the treatment of metastatic cancer of the prostate.
    Peeling WB
    Prog Clin Biol Res; 1989; 303():41-5. PubMed ID: 2528738
    [No Abstract]   [Full Text] [Related]  

  • 10. Zoladex with or without flutamide in the treatment of locally advanced or metastatic prostate cancer: interim analysis of an ongoing PONCAP study. Italian Prostatic Cancer Project (PONCAP).
    Boccardo F; Decensi A; Guarneri D; Rubagotti A; Oneto F; Martorana G; Giuliani L; Delli Ponti U; Petracco S; Cortellini P
    Eur Urol; 1990; 18 Suppl 3():48-53. PubMed ID: 2151277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical efficacy of long-term treatment with LH-RH analogue, ICI 118630 (Zoladex), in prostatic cancer patients. The Zoladex Multicenter Study Group].
    Usami M; Kotake T; Matsuda M; Okajima E; Osafune M; Akaza H; Nihsijima T; Aso Y; Araki T; Itatani H
    Hinyokika Kiyo; 1988 Nov; 34(11):2059-66. PubMed ID: 2977261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen].
    Usami M; Kotake T; Matsuda M; Okajima E; Osafune M; Akaza H; Niijima T; Aso Y; Araki T; Itatani H
    Hinyokika Kiyo; 1988 Oct; 34(10):1853-63. PubMed ID: 2977527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total androgen blockade with Zoladex plus flutamide vs. Zoladex alone in advanced prostatic carcinoma: interim report of a multicenter, double-blind, placebo-controlled study.
    Fourcade RO; Cariou G; Coloby P; Colombel P; Coulange C; Grise P; Mangin P; Soret JY; Poterre M
    Eur Urol; 1990; 18 Suppl 3():45-7. PubMed ID: 2151276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How can a nursing team participate in a clinical trial? Zoladex, flutamide trial].
    Guidez C
    Soins; 1990 Sep; (540):53. PubMed ID: 2151069
    [No Abstract]   [Full Text] [Related]  

  • 15. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.
    Crawford ED; Eisenberger MA; McLeod DG; Spaulding JT; Benson R; Dorr FA; Blumenstein BA; Davis MA; Goodman PJ
    N Engl J Med; 1989 Aug; 321(7):419-24. PubMed ID: 2503724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete androgen blockade: data from an EORTC 30853 trial.
    Denis L; Keuppens F; Robinson M; Mahler C; Smith P; Pinto de Carvalho AP; Newling D; Bono A; Sylvester R; De Pauw M
    Semin Urol; 1990 Aug; 8(3):166-74. PubMed ID: 2144656
    [No Abstract]   [Full Text] [Related]  

  • 17. Orchidectomy versus Zoladex plus Eulexin in patients with metastatic prostate cancer (EORTC 30853).
    Denis L; Robinson M; Mahler C; Smith P; Keuppens F; De Moura JL; Bono A; Newling D; Sylvester R; De Pauw M
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):951-9. PubMed ID: 2149508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group.
    Tyrrell CJ; Altwein JE; Klippel F; Varenhorst E; Lunglmayr G; Boccardo F; Holdaway IM; Haefliger JM; Jordaan JP
    J Urol; 1991 Nov; 146(5):1321-6. PubMed ID: 1834864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of an LH-RH analogue (Goeserelin acetate, 'Zoladex') with combined androgen blockade in advanced prostate cancer: final survival results of an international multicentre randomized-trial. International Prostate Cancer Study Group.
    Tyrrell CJ; Altwein JE; Klippel F; Jurincic-Winkler C; Varenhorst E; Lunglmayr G; Boccardo F; Holdaway IM; Haefliger JM; Jordaan JP
    Eur Urol; 2000 Feb; 37(2):205-11. PubMed ID: 10705200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A 79-year-old man with metastatic prostate cancer, treated with Zoladex, flutamide, calcitonin and Ostac, suffers from frequent troublesome sweating with palpitation and angina pectoris, especially at night. Is there a therapy?].
    Schmeller N
    Internist (Berl); 1992 Apr; 33(4):284. PubMed ID: 1535344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.